|
|
 |
|
Viewing report
|
|
|
|
Asthma – Executive Market Summary 2011
Timely Data Resources, Inc., June 2011, Pages: 17
The Asthma Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the asthma market, as well as sales of leading drugs and therapies are provided.
Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team
Each Executive Market Summary provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.
This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Impetigo – Executive Market Summary 2011
Disease and Therapy Review: Major Depressive Disorder
Disease and Therapy Review: Epilepsy
Disease and Therapy Review: HIV/AIDS
Disease and Therapy Review: Bipolar Disorder
Disease and Therapy Review: Lupus
Disease and Therapy Review: Oral Herpes
Disease and Therapy Review: Fibromyalgia
Disease and Therapy Review: Parkinsons Disease
Bladder Cancer – Executive Market Summary 2011
|
|
|
|
